Thursday, July 02, 2015 7:56:01 PM
Ramoil Management Partnership Agreements and Financial Reports
LAS VEGAS, NV--(Marketwired - Jun 8, 2015) - RAMOIL MANAGEMENT, Ltd. (OTC PINK: RAMO) announced today that they have secured a new partnership agreement. RAMO recently finalized a funding and distribution deal with United Enterprises that is integral to the company's ability to sustain long term growth and forecasts the generation of significant near-term revenues.
Company executives have been working diligently to finalize details of the agreement and are excited to announce this new deal. Tim Stokes, CEO of Ramoil Management, Ltd. said, "We are delivering on every pledge we've made to our shareholders and United Enterprises is a big part of that promise," he added, "UE (United Enterprises) is securing our ability to build on our partnership with (organizations like) Nature Elements and this deal will help generate revenues well into the six figures in the near term." United Enterprises is providing funding for CBD extraction equipment and will assist with the distribution of RAMO hydroponic products.
Stokes also commented on future partnerships mentioned in previous shareholder updates. "Today's announcement is a major step on our road to profitability. There are several partnership and consulting agreements we are working on that will allow us to scale our business exponentially." Stokes also alluded to the fact that this new agreement will significantly strengthen existing partnerships and will allow the company greater financial flexibility.
About Ramoil Management, Ltd. Ramoil Management, Ltd. (RAMO) is a development stage company focused on the operations of licensed and legal cultivation, extraction, manufacturing and retail facilities. The company's evolving business plan establishes domestic and international research and production laboratories working to perfect a proprietary strain of high CBD/low THC extraction compounds. The company plan focuses on revenues generated from the delivery of CBD extractions, concentrates and medicines using established wholesale and retail partnerships.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM